HFR Wealth Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-20,000
| Closed | -$136K | – | 62 |
|
|
2023
Q1 | $136K | Hold |
20,000
| – | – | 0.04% | 61 |
|
|
2022
Q4 | $148K | Hold |
20,000
| – | – | 0.04% | 63 |
|
|
2022
Q3 | $198K | Hold |
20,000
| – | – | 0.06% | 53 |
|
|
2022
Q2 | $218K | Hold |
20,000
| – | – | 0.07% | 55 |
|
|
2022
Q1 | $226K | Hold |
20,000
| – | – | 0.06% | 59 |
|
|
2021
Q4 | $314K | Hold |
20,000
| – | – | 0.08% | 49 |
|
|
2021
Q3 | $343K | Hold |
20,000
| – | – | 0.1% | 47 |
|
|
2021
Q2 | $430K | Buy |
+20,000
| New | +$430K | 0.13% | 43 |
|